SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®

NEXT STORY
APHL-CDC Fellowship Program Now Accepting Applicants for ’Unparalleled Opportunity’
PREV STORY
Oncotelic Initiates Phase 2 Trial Evaluating OT-101 in Combination with KEYTRUDA® for Mesothelioma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

author_avatar
NASDAQ Market News

The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019

author_avatar
NASDAQ Market News

Vitae Pharmaceuticals Announces Appointment of Carole Sable, M.D., as Chief Medical Officer

FORT WASHINGTON, Pa., June 06, 2016 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a ...

author_avatar
NASDAQ Market News